Navigation Links
Mylan Announces Appointment of John Montgomery as President, Asia Pacific

PITTSBURGH, Oct. 2 /PRNewswire-FirstCall/ -- Mylan Inc. (NYSE: MYL) today announced the appointment of John Montgomery to the position of President, Asia Pacific following the completion of Mylan's acquisition of Merck's Generics Group today.

Mr. Montgomery has worked for over 30 years in the pharmaceuticals industry and has extensive experience in both patented and generics pharmaceutical products in the UK, U.S. and Asia Pacific regions. At Merck Generics, he served as Regional Director, Asia Pacific, and CEO of Alphapharm, Merck Generic's business in Australia and the country's leading pharmaceutical company as measured by prescriptions. Prior to joining Merck, he spent 18 years with Warner Lambert in the UK, U.S. and Australia in roles including Business Director, Europe; Vice President, Cardiovascular; Vice President of Portfolio Management for North America; and Regional President Australia/New Zealand. He served five years as Chairman of the Generic Medicines Industry Association (GMiA) in Australia.

Mylan Vice Chairman and CEO Robert J. Coury commented: "I have seen first hand that John is a truly skilled leader with the vision that makes him a perfect fit for Mylan. He brings an impressive track record and true depth of experience to our senior team. Asia Pacific is an important region with an attractive growth profile, particularly in Japan. Under John's leadership, his business ranks number one in both Australia and New Zealand, and also ranks as the leading multinational generics company in Japan. I am confident that we are extremely well-placed to leverage the many opportunities we see in the region from our position as a new global leader in the generics and specialty pharmaceutical industry."

Mr. Montgomery said: "I am very pleased to be joining the management team at Mylan and excited to be part of a company that is firmly focused on growing its generics and specialty pharmaceuticals businesses. There are great similarities between the culture and history of Mylan and Alphapharm, as well as the other Asia Pacific companies. This common culture, values and focus, combined with true global scale, will drive growth and reinforce our leading positions in the region, as well as create additional opportunities for our future success."

Mylan Inc. is one of the world's leading quality generic and specialty pharmaceutical companies. The Company offers one of the industry's broadest and highest quality product portfolios, a robust product pipeline and a global commercial footprint through operations in more than 90 countries. Through its controlling interest in Matrix Laboratories Limited, Mylan has direct access to one of the largest active pharmaceutical ingredient (API) manufacturers in the world. Dey L.P., Mylan's fully integrated specialty business, provides the Company with innovative and diversified opportunities in the respiratory and allergy therapeutic areas.

Alphapharm is the largest pharmaceutical company in Australia as measured in prescriptions. The company develops, manufactures, markets and distributes generic and specialty prescription medicines. Merck Seiyaku Ltd. (Japan) was formed through the acquisitions of Hoei and Mohan, and is the fourth largest company in Japan's emerging generics market. The company is focused on specific therapeutic categories including antibiotics, oncology, skin and allergy, and metabolic diseases. Pacific Pharmaceuticals is the market leader in generics in New Zealand.

For more information about Mylan, please visit

SOURCE Mylan Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Mylan Wins Its Amlodipine Case With Pfizer
2. Mylan Announces Tentative FDA Approval for Its ANDA
3. Mylan Announces Final FDA Approval for Fluoxetine Capsules
4. PM announces a new health care order for India
5. Ramdoss Announces Introduction of RCH-II
6. Britain Announces Third Transfusion Related Mad Cow Case
7. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
8. Tibet Announces the Dalai Lama’s Tour of South Americ
9. NHS announces further Cost cutting Measures
10. Indian PM Announces Of Setting Up India Study Center At Tashkent
11. PowderMed Announces Needle-Less Flu Vaccine
Post Your Comments:
(Date:10/13/2015)... ... October 13, 2015 , ... Local Gold’s Gym franchise owner, Bryce ... on August 26. Berry, who owns and operates Gold's Gym Cheyenne in ... Gold’s Gyms in the United States. A brand leader in global fitness, Gold’s Gyms ...
(Date:10/13/2015)... ... October 13, 2015 , ... Breathing is one ... not breathe correctly. According to T’ai Chi (also spelled “Taiji”) and Qigong Grand-masters ... correctly, in concert with the 7,000 year old tradition they teach, can improve ...
(Date:10/13/2015)... (PRWEB) , ... October 13, 2015 , ... With Fall ... heat styling tool for this month’s Facebook Hair Styler Contest. , Enter to win! ... Contest Image Answering: What Is Your Favorite Hair Style? , 3. Follow us on ...
(Date:10/13/2015)... ... 13, 2015 , ... In an ongoing effort to provide ... Southlake, Texas, child development and pediatric therapy center, is working with TRICARE to ... their options for receiving this kind of care for affected children. Because of ...
(Date:10/13/2015)... MD (PRWEB) , ... October 13, 2015 , ... ... retailing sustainable and eco-friendly home furnishings and décor, today announced it closed on ... equity investor. The funds will be used to support the Company’s continued rapid ...
Breaking Medicine News(10 mins):
(Date:10/13/2015)... Oct. 13, 2015   Happy Vitals ... laboratory home testing kit for breast milk.  ... provide an unparalleled, detailed assessment of the ... proteins, carbs and key vitamins—all charted over ... personal health tracking.  In addition, Happy Vitals also ...
(Date:10/13/2015)... Calif. , Oct. 13, 2015   Rosa ... advisory firm in Quantitative Systems Pharmacology (QSP)/ PhysioPD™ , ... Engineer, will lead a workshop at the QSP ... in Boston, MA.  The conference ... pharmaceutical drug development.  Dr. Friedrich,s workshop is entitled "Using ...
(Date:10/13/2015)... -- World Thrombosis Day Interactive Infographic   ... --> World Thrombosis Day Interactive Infographic ... vital global awareness of thrombosis, its causes, risk ... formation of potentially deadly blood clots in the ... (VTE) - or the artery (arterial thrombosis) [1]  - ...
Breaking Medicine Technology: